Access cutting-edge eczema treatment through this clinical trial at a research site in North Little Rock. Study-provided care at no cost to qualified participants.
Access eczema specialists in North Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related eczema treatment provided free
This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 years of age who have moderate-to-severe eczema. Research study participants who meet the study criteria will be assigned by chance (like the flip of a coin) to receive either abrocitinib test medicine or placebo (pretend medicine that looks just like the test medicine) for 16 weeks. The study will last for about 24 weeks in total.
Sponsor: Pfizer
Check if you qualify for this eczema clinical trial in North Little Rock, AR
If you're searching for eczema treatment options in North Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our North Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced eczema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.